Pharmacotherapy of diabetes and cancer risk
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-10-01
著者
-
Hashiramoto Mitsuru
Division of Diabetes and Endocrinology, Department of Medicine, Kawasaki Medical School
-
Kaku Kohei
Division Of Diabetes And Endocrinology Department Of Internal Medicine Kawasaki Medical School
-
Kaku Kohei
Division Of Diabetes Metabolism And Endocrinology Kawasaki Medical School
-
Hashiramoto Mitsuru
Division Of Diabetes Metabolism And Endocrinology Kawasaki Medical School
関連論文
- Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy
- Low, but Physiological, Concentration of GLP-1 Stimulates Insulin Secretion Independent of the cAMP-Dependent Protein Kinase Pathway
- Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus
- The health status of Japanese people living in the UK
- First Phase of Glucose-Stimulated Insulin Secretion From MIN 6 Cells Does Not Always Require Extracellular Calcium Influx
- Pharmacokinetics and Pharmacodynamics of Glimepiride in Type 2 Diabetic Patients : Compared Effects of Once- versus Twice-daily Dosing
- Effect of Intensive Lipid-Lowering Therapy With Rosuvastatin on Progression of Carotid Intima-Media Thickness in Japanese Patients : Justification for Atherosclerosis Regression Treatment (JART) Study
- A single-nucleotide polymorphism in the human THADA gene is associated with circulating resistin in the general Japanese population
- Pharmacotherapy of diabetes and cancer risk
- The PREDICTIVE^ Study : a multinational, prospective observational study to evaluate the safety and efficacy of insulin detemir treatment in patients with type 1 and 2 diabetes-data from the Japan cohort
- International clinical harmonization of glycated hemoglobin in Japan : From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
- Intensive Lipid-Lowering Therapy for Slowing Progression as Well as Inducing Regression of Atherosclerosis in Japanese Patients:Subanalysis of the JART Study
- Effect of Long-Term Intensive Lipid-Lowering Therapy With Rosuvastatin on Progression of Carotid Intima-Media Thickness:– Justification for Atherosclerosis Regression Treatment (JART) Extension Study –
- Errata: Intensive Lipid-Lowering Therapy for Slowing Progression as Well as Inducing Regression of Atherosclerosis in Japanese Patients [International Heart Journal Vol. 54 (2013) No. 1 p. 33-39]
- Replication study for the association of a single-nucleotide polymorphism, rs3746876, within KCNJ15, with susceptibility to type 2 diabetes in a Japanese population
- Longer HSD11B2 CA-repeat in impaired glucose tolerance and type 2 diabetes
- Can Intensive Lipid-Lowering Therapy Improve the Carotid Intima-Media Thickness in Japanese Subjects Under Primary Prevention for Cardiovascular Disease?: The JART and JART Extension Subanalysis
- Effect of Long-Term Intensive Lipid-Lowering Therapy With Rosuvastatin on Progression of Carotid Intima-Media Thickness : Justification for Atherosclerosis Regression Treatment (JART) Extension Study